Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-11.0%
5Y CAGR+8.0%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-11.0%/yr
vs -4.8%/yr prior
5Y CAGR
+8.0%/yr
Recent deceleration
Acceleration
-6.3pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$84.20M-47.6%
2024$160.65M+24.9%
2023$128.61M+7.5%
2022$119.61M+24.0%
2021$96.48M+68.1%
2020$57.39M-40.7%
2019$96.78M-33.5%
2018$145.50M+96.3%
2017$74.11M+52.6%
2016$48.57M-